Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-galactoside-containing oligosaccharides are a class of carbohydrates characterized by terminal α-galactosyl linkages to other monosaccharides, typically glucose or fructose.[1][2] Common examples include raffinose and stachyose (collectively known as raffinose family oligosaccharides) and various forms of galacto-oligosaccharides (GOS) synthesized by enzymatic processes. These molecules are not receptors, enzymes, or canonical drug targets, but serve as prebiotics: when ingested, they selectively stimulate the growth and activity of beneficial gut bacteria such as Bifidobacterium and Lactobacillus, modulating the gut microbiome, lipid metabolism, immune responses, and intestinal barrier function.[2][4] Some α-galactoside-containing oligosaccharides are naturally present in legumes and other plant foods, contributing to dietary fiber content, while others can be formulated as dietary supplements. Their bioactivity is mediated by fermentation and selective utilization by gut microbes, not by interaction with drug molecules or direct receptor/enzyme targeting. Important note: "Alpha-galactoside-containing oligosaccharides" refers to a class of carbohydrates, not a molecular drug target, receptor, or enzyme. They are sometimes substrates for specific enzymes (e.g., alpha-galactosidase) but are not themselves canonical targets for therapeutics.[1][2][4]
Serve as prebiotics: fermented by gut bacteria to produce short-chain fatty acids, change microbiome composition. Can inhibit pathogenic bacterial adhesion by occupying binding sites in the intestine. Modulate host metabolism through gut microbial metabolites
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-galactoside-containing oligosaccharide (None commonly used).